AI assistant
NEOGENOMICS INC — Director's Dealing 2022
Jun 24, 2022
32227_dirs_2022-06-24_de912b38-5350-4713-816a-4961d169d338.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-06-22
Reporting Person: Dieter Cynthia J (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-22 | Common Stock | F | 57 | — | Disposed | 18580 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $28.35 | 2027-06-22 | Common Stock (3968.0) | 3968 | Direct |
| Stock Option (Right to Buy) | $53.17 | 2028-03-02 | Common Stock (7034.0) | 7034 | Direct |
| Stock Option (Right to Buy) | $21.41 | 2029-03-01 | Common Stock (22805.0) | 22805 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the June 22, 2022 vesting of restricted stock.
F2: On June 22, 2020, Ms. Dieter was granted 3,968 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3: On March 2, 2021, Ms. Dieter was granted 7,034 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4: On March 1, 2022, Ms. Dieter was granted 22,805 stock options. These options vest ratably over the first four anniversary dates of the grant date.